Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic response

Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic response

PurposeCancer remains a major global cause of death, with rising incidence influenced by environmental factors. The THOC5 gene, part of the THO complex, has emerged as a potential regulator in cancer biology. This study investigates THOC5 expression across various cancers, its role in prognosis, and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jin-Shu Pang, Yu Yang, Li Liang, Yu-Jia Zhao, Jin-Dan Li, Li-Peng Li, Xue-Xin Wei, Rui-Zhi Gao, Rong Wen, Yun He, Hong Yang, Xiu-Mei Bai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Medicine
Subjects:	THOC5 hepatocellular carcinoma expression prognosis ICB therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1596120/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Tumor-associated tertiary lymphoid structures response during immunotherapy
by: Ileana Soto Mauldin, et al.
Published: (2025-04-01)

The host genes influencing Clostridioides difficile infection and the potential role of intestinal Lactobacillus acidophilus: a Mendelian randomization and animal model study
by: Yuxin Sun, et al.
Published: (2025-07-01)

Design and verification of a DMA controller based on the ICB bus
by: Su Xing, et al.
Published: (2024-01-01)

Leveraging immune checkpoint inhibitors in lung cancer patients with pre-existing autoimmune disease: clinical insights, optimal timing, and predictive biomarkers for optimal treatment outcomes
by: Hui Yang, et al.
Published: (2025-05-01)

Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC
by: Jiayi Hu, et al.
Published: (2025-05-01)

Visual Outcomes and Patient Satisfaction of Enhanced Monofocal Intraocular Lens in Phacovitrectomy for Idiopathic Epiretinal Membrane
by: Ji Youn Choi, et al.
Published: (2024-09-01)

Integrating single-cell and bulk RNA sequencing data to characterize the heterogeneity of glycan-lipid metabolism polarization in hepatocellular carcinoma
by: Peng Lin, et al.
Published: (2025-03-01)

A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan‐Cancer
by: Weiquan Hu, et al.
Published: (2025-03-01)

CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma
by: Liang Yang, et al.
Published: (2025-03-01)

Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1
by: Xin Zang, et al.
Published: (2024-09-01)

Incomplete Thermal Ablation-Induced FOXP4-Mediated Promotion of Malignant Progression in Liver Cancer via NDST2
by: Wan W, et al.
Published: (2024-10-01)

Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis
by: Jin Li, et al.
Published: (2025-01-01)

Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma
by: Shu-Xian Li, et al.
Published: (2025-05-01)

The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
by: Wenhua Xia, et al.
Published: (2025-01-01)

Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy
by: Liu C, et al.
Published: (2025-07-01)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
by: Cheng‐Qian Zhong, et al.
Published: (2018-06-01)

Tissue‐Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy
by: Luming Xu, et al.
Published: (2025-03-01)

Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer
by: Ella A. Eklund, et al.
Published: (2025-02-01)

Chemokines: Orchestration of the Tumor Microenvironment and Control of Hepatocellular Carcinoma Progression
by: Jiezuan Yang, et al.
Published: (2025-04-01)

Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications
by: Huihai Yang, et al.
Published: (2025-07-01)

Membranous Overexpression of Fibronectin Predicts Microvascular Invasion and Poor Survival Outcomes in Patients with Hepatocellular Carcinoma
by: Yoon Jung Hwang, et al.
Published: (2025-03-01)

DNA methylation-driven genes in hepatocellular carcinoma patients: insights into immune infiltration and prognostic implications
by: Zhi Zhang, et al.
Published: (2025-04-01)

Comparison of thermal ablation and surgery for hyperparathyroidism: a meta-analysis
by: Huan-yu Cui, et al.
Published: (2025-12-01)

The Establishment of Double-Transgenic Mice that Co-Express the appA and MxA Genes Mediated by Type A Spermatogonia In vivo
by: Li-jing BAI, et al.
Published: (2014-12-01)

Interaction mechanism of Soil-ICB Grid
by: Islam Elkorashi, et al.
Published: (2022-06-01)

Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models
by: Brajesh P. Kaistha, et al.
Published: (2024-12-01)

Evaluation of PDZD11 in hepatocellular carcinoma: prognostic value and diagnostic potential in combination with AFP
by: Yiyun Ni, et al.
Published: (2025-03-01)

A pH/MMP-9 smart dual-responsive liposome GBE@LP co-delivers and controls the release of GB1107/BMS1166/Enzalutamide for liver cancer immunotherapy
by: Shijia Lu, et al.
Published: (2025-06-01)

Development of a PPP1R14B-associated immune prognostic model for hepatocellular carcinoma
by: Ligang Zhao, et al.
Published: (2025-08-01)

Prognostic significance of combined PCPE-1 and α-fetoprotein for hepatocellular carcinoma
by: Ruhua Zhang, et al.
Published: (2025-01-01)

Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma
by: Zhengyan Li, et al.
Published: (2025-01-01)

Nomogram based on the neutrophil-to-lymphocyte ratio and MR diffusion quantitative parameters for predicting Ki67 expression in hepatocellular carcinoma from a prospective study
by: Yu-chen Wei, et al.
Published: (2024-12-01)

Platelet-albumin-bilirubin versus albumin–bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection
by: Haojie Yang, et al.
Published: (2025-05-01)

Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma
by: Kangqiang Peng, et al.
Published: (2024-12-01)

Machine learning-driven multi-omics analysis identifies a prognostic gene signature associated with programmed cell death and metabolism in hepatocellular carcinoma
by: Xiang Li, et al.
Published: (2025-08-01)

MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma
by: Ja Kyung Yoon, et al.
Published: (2025-05-01)

Establishment of prognostic risk model related to disulfidptosis and immune infiltration in hepatocellular carcinoma
by: Zhe Xu, et al.
Published: (2024-12-01)

Impact of frailty on the long-term prognosis of the elderly with hepatocellular carcinoma treated with transarterial chemoembolization
by: Yu-Fei Shao, et al.
Published: (2025-04-01)

Calcium ion-binding genes can predict tumor mutation burden and immune checkpoint blockade response in a pan-cancer model
by: Wan-Yu Lin, et al.
Published: (2025-07-01)

Elevated expression of ANAPC1 in lung squamous cell carcinoma: clinical implications and mechanisms
by: Xiao-Song Chen, et al.
Published: (2025-12-01)